RxDoctor Payments DataLook up a doctor →

Charles Farber, PhD

Hematology & Oncology · Morristown, NJNPI 1144218215

Payments from drug & device makers

$4,646,207in general payments, 2019–2025

Across 2,165 payments — averaging $2146.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Beigene, Ltd.$2.6M
  • Beone Medicines Ltd.$277K
  • Incyte Corporation$243K
  • Sanofi US Services Inc.$239K
  • Seagen Inc.$214K
  • AstraZeneca$144K
  • plus $880K from 54 others
$34,777in research payments, 2019–2025

Across 12 payments — averaging $2898.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$32K
  • Regeneron$1K
  • Pfizer$940

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Beigene, Ltd.297$2,649,115
Beone Medicines Ltd.13$276,974
Incyte Corporation226$242,918
Sanofi US Services Inc.24$239,121
Seagen Inc.145$213,524
AstraZeneca(2 entities)94$144,009
AbbVie45$143,562
Acerta Pharma LLC4$69,898
Bristol Myers Squibb80$66,599
Morphosys AG9$58,801
Beigene USA, Inc.36$54,440
Gilead(2 entities)82$54,170
Eli Lilly11$47,620
Genentech USA, Inc.51$40,820
Pfizer89$37,720
Genentech, Inc.12$37,522
Merck67$37,486
Regeneron17$37,137
Otsuka Pharmaceutical Co., Ltd.3$29,113
Amgen39$27,345
GSK42$26,997
Astellas Pharma Global Development2$26,000
Takeda Pharmaceuticals U.S.A., Inc.25$16,025
Genmab U.S., Inc.34$14,119
E.r. Squibb & Sons, L.L.C.89$7,865
Sanofi63$6,847
Pharmacyclics LLC, An Abbvie Company9$4,541
Daiichi Sankyo Inc.93$3,729
Bayer23$3,690
Novartis92$3,490
Verastem, Inc.3$3,482
ADC Therapeutics America, Inc.3$3,298
Morphosys, US Inc.5$3,137
Johnson & Johnson(2 entities)54$3,126
Jazz Pharmaceuticals Inc.10$2,623
Beone Medicines USA, Inc.1$1,909
Exelixis Inc.8$1,257
TG Therapeutics, Inc.3$764
Eisai Inc.44$670
Astellas Pharma US Inc22$559
Regeneron Healthcare Solutions, Inc.12$404
Mirati Therapeutics, Inc.18$277
Karyopharm Therapeutics Inc.11$245
Pharmacosmos Therapeutics Inc.9$240
Lilly USA, LLC12$210
EMD Serono, Inc.12$198
Portola Pharmaceuticals, LLC1$182
AVEO Pharmaceuticals, Inc.4$171
Sanofi-aventis U.S. LLC4$158
Array Biopharma Inc11$158
Foundation Medicine, Inc.5$132
Pharmaessentia USA Corporation8$129
Stemline Therapeutics Inc.7$120
Agios Pharmaceuticals, Inc.4$110
Ipsen Biopharmaceuticals, Inc7$107
Taiho Oncology, Inc.7$107
Geron Corporation1$97
Adaptive Biotechnologies Corporation1$95
Sun Pharmaceutical Industries Inc.4$91
Puma Biotechnology, Inc.6$89

How this compares

$4,646,207 in reported general payments places this provider in the 95th percentile of 362 hematology & oncology providers in New Jersey.

See all hematology & oncology providers in New Jersey →

Medicare billing

Part B allowed, 2024
$248,987
Medicare patients
448
Services billed
3,056

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Morristown

See the full list for New Jersey →

Where these figures come from

Is this you, or does something look wrong? →